Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

[Postpartum haemorrhage in Umbria: accuracy of the regional health information system for the code ICD-9-CM 666.x.]

Abraha I, Montedori A, Giovannini G, Cozzolino F, Orso M, De Giorgi M, Franchini D, Di Renzo GC, Angelozzi P, Micheli M, Germani A, Carloni D, Scaccetti A, Palmieri G, Casali M, Nenz CMG, Gargano E, Pazzaglia M, Agea E, Moscetti C, Berchicci L, Tesoro S, Albi N, Epicoco G, Marchesi M.

Recenti Prog Med. 2019 Sep;110(9):420-425. doi: 10.1701/3215.31935. Italian.

PMID:
31593178
2.

[Epidemiology of postpartum hemorrhages in the Umbrian population in the years 2006-2017.]

Abraha I, Montedori A, Giovannini G, Cozzolino F, Orso M, De Giorgi M, Franchini D, Di Renzo GC, Angelozzi P, Micheli M, Germani A, Carloni D, Scaccetti A, Palmieri G, Casali M, Nenz CMG, Gargano E, Pazzaglia M, Agea E, Moscetti C, Berchicci L, Tesoro S, Albi N, Epicoco G, Marchesi M.

Recenti Prog Med. 2019 Sep;110(9):412-419. doi: 10.1701/3215.31934. Italian.

PMID:
31593177
3.

Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.

Cicinelli MV, Marchese A, Miserocchi E, Giuffré C, Berchicci L, Querques G, Bandello F, Modorati GM.

Ocul Immunol Inflamm. 2019 Aug 8:1-10. doi: 10.1080/09273948.2019.1616769. [Epub ahead of print]

PMID:
31393199
4.

Oral iron-based interventions for prevention of critical outcomes in pregnancy and postnatal care: An overview and update of systematic reviews.

Abraha I, Bonacini MI, Montedori A, Di Renzo GC, Angelozzi P, Micheli M, Germani A, Carloni D, Scaccetti A, Palmieri G, Casali M, Nenz CMG, Gargano E, Pazzaglia M, Agea E, Berchicci L, Tesoro S, Albi N, Minelli O, Pasqua BL, Onorato M, Epicoco G, Marchesi M.

J Evid Based Med. 2019 May;12(2):155-166. doi: 10.1111/jebm.12344.

PMID:
31144465
5.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriček I.

Bone Marrow Transplant. 2019 May;54(5):662-673. doi: 10.1038/s41409-018-0340-0. Epub 2018 Dec 7. Review.

PMID:
30531954
6.

Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriček I.

Biol Blood Marrow Transplant. 2019 Feb;25(2):e46-e54. doi: 10.1016/j.bbmt.2018.11.021. Epub 2018 Nov 24. Review.

PMID:
30481594
7.

Ocular Toxicity of Mirvetuximab.

Corbelli E, Miserocchi E, Marchese A, Giuffrè C, Berchicci L, Sacconi R, Bandello F, Modorati GM.

Cornea. 2019 Feb;38(2):229-232. doi: 10.1097/ICO.0000000000001805.

PMID:
30379722
8.

Diagnostic, preventive and therapeutic evidence in obstetrics for the implementation of patient blood management: a systematic review protocol.

Abraha I, Montedori A, Di Renzo GC, Angelozzi P, Micheli M, Carloni D, Germani A, Palmieri G, Casali M, Nenz CMG, Gargano E, Pazzaglia M, Berchicci L, Tesoro S, Epicoco G, Giovannini G, Marchesi M; Umbria PBM Group.

BMJ Open. 2018 Oct 15;8(10):e021322. doi: 10.1136/bmjopen-2017-021322.

9.

Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment.

Pennisi M, Berchicci L, Miserocchi E, Mussetti A, Cacioppo V, David A, Scialdone A, Lorusso I, Modorati G, Corradini P, Montefusco V.

Leuk Lymphoma. 2019 Feb;60(2):477-482. doi: 10.1080/10428194.2018.1480770. Epub 2018 Jul 22.

PMID:
30033858
10.

Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center.

Berchicci L, Rabiolo A, Marchese A, Iuliano L, Gigliotti C, Miserocchi E, Bandello F, Modorati G.

Ocul Surf. 2018 Jul;16(3):314-321. doi: 10.1016/j.jtos.2018.04.001. Epub 2018 Apr 4.

PMID:
29625303
11.

Dexamethasone intravitreal implant in serpiginous choroiditis.

Miserocchi E, Berchicci L, Iuliano L, Modorati G, Bandello F.

Br J Ophthalmol. 2017 Mar;101(3):327-332. doi: 10.1136/bjophthalmol-2015-307820. Epub 2016 Jun 2.

PMID:
27256717
12.

Retinal Hereditary and Degenerative/Dystrophic Diseases (Non-Age-Related Macular Degeneration).

Battaglia Parodi M, La Spina C, Corradetti G, Berchicci L, Petruzzi G, Bandello F.

Dev Ophthalmol. 2016;55:205-11. doi: 10.1159/000431125. Epub 2015 Oct 26. Review.

PMID:
26502105
13.

Photosensitizers and Photodynamic Therapy: Verteporfin.

Battaglia Parodi M, La Spina C, Berchicci L, Petruzzi G, Bandello F.

Dev Ophthalmol. 2016;55:330-6. doi: 10.1159/000434704. Epub 2015 Oct 26. Review.

PMID:
26501167
14.

Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.

Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.

Br J Ophthalmol. 2016 Jun;100(6):782-6. doi: 10.1136/bjophthalmol-2015-306790. Epub 2015 Sep 22.

PMID:
26396026
15.

Tear osmolarity in ocular graft-versus-host disease.

Berchicci L, Iuliano L, Miserocchi E, Bandello F, Modorati G.

Cornea. 2014 Dec;33(12):1252-6. doi: 10.1097/ICO.0000000000000283.

PMID:
25343699
16.

Tear film osmolarity in ocular mucous membrane pemphigoid.

Miserocchi E, Iuliano L, Berchicci L, Bandello F, Modorati G.

Cornea. 2014 Jul;33(7):668-72. doi: 10.1097/ICO.0000000000000148.

PMID:
24858022
17.

Spectral-domain optical coherence tomography evaluation of vitreoretinal adhesions in idiopathic epiretinal membranes.

Pierro L, Gagliardi M, Giatsidis S, Iuliano L, Berchicci L, Battaglia Parodi M.

Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1041-7. doi: 10.1007/s00417-013-2546-6. Epub 2014 Jan 3.

PMID:
24384800
18.

Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.

Berchicci L, Miserocchi E, Di Nicola M, La Spina C, Bandello F, Modorati G.

Eur J Ophthalmol. 2014 May-Jun;24(3):293-8. doi: 10.5301/ejo.5000394. Epub 2013 Nov 12.

PMID:
24242216
19.

Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.

Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F.

Am J Ophthalmol. 2014 Feb;157(2):374-377.e2. doi: 10.1016/j.ajo.2013.10.015. Epub 2013 Nov 6.

PMID:
24211865
20.

Evidence for anti-VEGF treatment of diabetic macular edema.

Bandello F, Berchicci L, La Spina C, Battaglia Parodi M, Iacono P.

Ophthalmic Res. 2012;48 Suppl 1:16-20. doi: 10.1159/000339843. Epub 2012 Aug 21. Review.

PMID:
22907145
21.

Clinical application of an in-house ELISPOT assay in patients with suspicious tuberculous uveitis and no signs of active tuberculosis.

Modorati G, Berchicci L, Miserocchi E, Scarpellini P, Mantegani P, Bandello F, Ortis C.

Eur J Ophthalmol. 2012 Sep-Oct;22(5):808-13. doi: 10.5301/ejo.5000121.

PMID:
22344468
22.

FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions.

La Starza R, Crescenzi B, Nofrini V, Barba G, Matteucci C, Brandimarte L, Pierini V, Testoni N, Musto P, Paolini S, Gianfelici V, Storlazzi CT, Pierini A, Berchicci L, Gorello P, Mecucci C.

Leuk Res. 2012 Jan;36(1):37-41. doi: 10.1016/j.leukres.2011.08.004. Epub 2011 Sep 13.

PMID:
21920603
23.

MN1-ETV6 fusion gene arising from MDS with 5q-.

Nofrini V, Berchicci L, La Starza R, Gorello P, Di Giacomo D, Arcioni F, Pierini V, Crescenzi B, Romoli S, Matteucci C, Mecucci C.

Leuk Res. 2011 Jul;35(7):e123-6. doi: 10.1016/j.leukres.2011.03.019. Epub 2011 May 19. No abstract available.

PMID:
21600651
24.

NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.

La Starza R, Matteucci C, Gorello P, Brandimarte L, Pierini V, Crescenzi B, Nofrini V, Rosati R, Gottardi E, Saglio G, Santucci A, Berchicci L, Arcioni F, Falini B, Martelli MF, Sambani C, Aventin A, Mecucci C.

PLoS One. 2010 Sep 21;5(9):e12855. doi: 10.1371/journal.pone.0012855.

25.

A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement.

La Starza R, Brandimarte L, Pierini V, Nofrini V, Gorello P, Crescenzi B, Berchicci L, Matteucci C, Romoli S, Beacci D, Rosati R, Martelli MF, Mecucci C.

Cancer Genet Cytogenet. 2009 Sep;193(2):109-11. doi: 10.1016/j.cancergencyto.2009.04.015.

PMID:
19665072
26.

Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.

Ballanti S, Mastrodicasa E, Bolli N, Lotti F, Capolsini I, Berchicci L, Merigiola C, Giordano G, Tabilio A.

Nat Clin Pract Oncol. 2007 Dec;4(12):722-5.

PMID:
18037876

Supplemental Content

Loading ...
Support Center